Cardiac performance monitoring system for use with mobile communications devices

ABSTRACT

Described herein are apparatuses (e.g., devices, systems, software), and methods for monitoring the cardiac health of a patient. The apparatuses and methods may include a smartphone or hand held computing device having an accelerometer. The apparatus may also include a device with a plurality of electrodes integral with or attached to the smartphone. The devices can be placed on a patient&#39;s chest to measure electrical signals and vibrations on the chest caused by the heartbeat. The measurements can generate a seismocardiogram (SCG) and in some variations an electrocardiogram (ECG). The apparatuses and methods can analyze the data in the SCG to produce a measure of the cardiac function. Changes in such measures can provide an early warning for potential cardiac problems and signal the need for the patient to seek treatment prior to a fatal cardiac event.

CROSS REFERENCE TO RELATED APPLICATIONS

This patent application is a continuation of U.S. patent applicationSer. No. 14/015,303, filed Aug. 30, 2013, titled “CARDIAC PERFORMANCEMONITORING SYSTEM FOR USE WITH MOBILE COMMUNICATIONS DEVICES,”Publication No. US-2014-0066798-A1, which claims priority to U.S.Provisional Patent Application No. 61/695,278, filed Aug. 30, 2012 andtitled “CARDIAC PERFORMANCE MONITORING SYSTEM FOR USE WITH MOBILECOMMUNICATIONS DEVICES,” which is herein incorporated by reference inits entirety.

This material may be related to: U.S. patent application Ser. No.13/964,490, filed Aug. 12, 2013, titled “HEART MONITORING SYSTEM USABLEWITH A SMARTPHONE OR COMPUTER,” Publication No. US-2013-0331663-A1,which is a divisional of U.S. patent application Ser. No. 12/796,188,filed Jun. 8, 2010 and titled “HEART MONITORING SYSTEM USABLE WITH ASMART PHONE OR COMPUTER,” now U.S. Pat. No. 8,509,882; U.S. patentapplication Ser. No. 13/108,738, filed May 16, 2011 and titled“WIRELESS, ULTRASONIC PERSONAL HEALTH MONITORING SYSTEM,” nowPublication No. US-2011-0301439-A1; and U.S. Pat. No. 8,301,232, filedMar. 14, 2012 and titled “WIRELESS, ULTRASONIC PERSONAL HEALTHMONITORING SYSTEM,” each of which is herein incorporated by reference inits entirety.

INCORPORATION BY REFERENCE

All publications and patent applications mentioned in this specificationare herein incorporated by reference in their entirety to the sameextent as if each individual publication or patent application wasspecifically and individually indicated to be incorporated by reference.

FIELD

This patent application discloses inventive concept(s) related generallyto systems, methods and devices, including hardware, firmware andsoftware, for measuring and/or analyzing cardiac function in a user orpatient with mobile communications and/or computing devices such assmartphones. In particular, described herein are methods, devices andsystems for using a mobile telecommunications device to measure one ormore parameters including cardiac parameters such as seismocardiograms.The system may be simple, lightweight and may adapt existing consumermobile devices making it appropriate for home and patient-operated use.

BACKGROUND

At-home monitoring of cardiac activity and metrics of cardiac activityis an area of intense interest, because it offers the potential forvastly improving patient quality of life and life expectancy, as well assubstantially reducing health care costs. For example congestive heartfailure (CHF) is a common, costly, disabling, and potentially deadlycondition. In developed countries, around 2% of adults suffer from heartfailure, but in those over the age of 65, this increases to 6-10%.Although warning factors for CHF episodes (symptoms), including changesin cardiac rhythm, heart rate, and heart rate variability, have beenidentified, monitoring of patient's outside of the hospital setting hasproven difficult and expensive. Thus, there is a well-established needfor such (e.g., “at home”) monitoring.

Congestive heart failure, myocardial infarction, and other cardiacproblems are fatal to a large number of people every year. Congestiveheart failure and other cardiac problems can happen suddenly and befatal without immediate treatment. Patients with cardiac problems canfeel fine after being treated by a doctor to evaluate the patient'smedication intake and cardiac functions. However, cardiac problems canarise between appointments and possibly lead to fatal cardiac events.

Changes in federal regulations of Medicare can penalize hospitals foremergency room admission of patients recently treated for cardiacproblems. The new penalties provide additional incentives for thehospitals and doctors to monitor the cardiac health of the patient toensure good cardiac health between appointments or to catch possibleproblems before a cardiac event requiring a visit to the emergency roomoccurs. Therefore, improved monitoring of the cardiac health of thepatient is desired. Early diagnosis of a potential symptom or problemcan result in treatment that prevents a fatal cardiac event.

Described herein are methods, devices, and systems for monitoringcardiac performance that may address this need. In particular, describedherein are methods and systems (including software/firmware) for usingor adapting for use one or more widely available communications ortelecommunications devices, such as smart phones, tablet computers, orportable computers, to monitor one or more cardiac performanceindicators, including a seismocardiogram (SCG). These methods and systemmay record, analyze, receive, and/or send cardiac performanceinformation (including but not limited to digital health information)and/or indicators of cardiac performance (e.g., “indexes”) that may beunderstood by medical professionals. The devices, systems and methodsmay also provide direct patient feedback, both in assisting the patientto take (by themselves) a correct and/or accurate reading, and forproviding an indicator of general health, including triggering an alarm.For example, a patient may record and provide access to detected healthinformation (e.g., blood pressure, ECG, SCG, blood sugar, temperature,telemetry, etc.) to medical professionals using the methods and devicesdescribed herein. Access may be provided by uploading the medicalinformation to a server and/or website; the website may be used tostore, provide remote access to the user and/or qualified medicalprofessionals, or analyze the health information.

Although this application focuses primarily on the use ofseismocardiography using a personal communications device (e.g., smartphone), many of the principles described herein may be applied to othercardiac metrics and indices. Further, some of the principles describedherein may be applied to methods and systems that may be used without apersonal communications device.

Although the prior art has acknowledged the need for personal (e.g.,at-home) monitoring devices, including those capable of performingand/or analyzing seismocardiography, no effective, lightweight, portableand patient-ready monitoring device has yet been developed or madeavailable. For example, “Mechanisms Underlying Isovolumic Contractionand Ejection Peaks in Seismocardiogram Morphology” by Gurev et al.(Journal of Medical and Biological Engineering, 32(2): 103-110 (2012))disclose a prior art setup for simultaneously taking a SCG and ECG. Theequipment used in Gurev (see FIG. 1) is large, expensive, andimpractical for home use. In contrast, the devices and methods disclosedherein enable the user to take an ECG and SCG at home using a hand helddevice, such as a mobile telecommunications device, as shown in FIG. 2.

“Seismocardiography—a non-invasive method of assessing systolic anddiastolic left ventricular function in ischaemic heart disease” byKorzeniowska-Kubacka et al. (Folia Cardiol. 2006, Vol. 13, No. 4, pages319-325) discloses using a seismocardiograph to measure cardiac functionduring exercise. The methods and apparatuses are administered by amedical professional in a medical office and require larger equipmentthat is not practical for home use or for a patient to self administer.

“A continuous, wearable, and wireless heart monitor using headballistocardiogram (BCG) and head electrocardiogram (ECG).” By He et al.(Conf. Proc. IEEE Eng. Med. Biol. Soc. 2011, pages 4729-32) discloses awearable heart monitoring sensor that has the form factor of a hearingaid that can communicate wirelessly with a computer device. However, thesystem requires the use of a separate piece, such as the in ear sensor,along with a computing device. The use of multiple pieces makes it moredifficult for elderly patients to use the setup and decreases thelikelihood that the patient will use the device.

U.S. Patent Application Publication No. 2009/0024045 discloses using animplanted medical device to directly measure various cardiac functions.The measurements require that the medical device is implanted within thepatient's body. The methods, systems, and devices disclosed herein offersignificant advantages because they do not require an invasive implantedmedical device and can be used to quickly and conveniently measure anumber of cardiac parameters with the patient in the comfort of theirhome.

U.S. Pat. No. 6,024,705 discloses using a seismic sensor to take an SCGalong with a computer to analyze the waveform and output a numericalvalue representing cardiac performance. These devices are alsoimpractical for home use or self-testing. The methods and devices arenot used (or compatible with use) with a mobile telecommunicationsdevice.

U.S. patent application Ser. No. 12/796,188, filed Jun. 8, 2010 andtitled “HEART MONITORING SYSTEM USABLE WITH A SMART PHONE OR COMPUTER,”now U.S. Pat. No. 8,509,882 and U.S. patent application Ser. No.13/108,738, filed May 16, 2011 and titled “WIRELESS, ULTRASONIC PERSONALHEALTH MONITORING SYSTEM,” now Publication No. US-2011-0301439-A1,describe ECG monitors that convert ECG data into ultrasound signals thatcan be received by a telecommunications device such as a smartphone andthen stored, analyzed, and/or displayed. The instant application extendsand adapts this teaching and may be used with any of the systems,methods, and devices described herein.

SUMMARY OF THE DISCLOSURE

In general, the devices, systems, software, and methods described hereinallow an operator, including the patient, to measure a metric of cardiacperformance in a simple and inexpensive fashion. The invention mayoperate with a preexisting mobile telecommunication device having anaccelerometer (or adapted for use with an accelerometer) withoutrequiring additional instrumentation.

In general, the systems described herein may be referred to as cardiacperformance monitoring systems. In some variations these systems may bereferred to as SCG (or seismocardiogram) monitoring systems. Any ofthese systems may include control logic for controlling a mobiletelecommunications device, and in particular, for controlling theaccelerometer of a mobile telecommunications device so that it detectsand in some variations records an SCG signal. A cardiac performancemonitoring system may be configured to include software (an “app” orapplications) for a mobile telecommunications device (e.g., mobiletelecommunications devices, smart phones, etc.) that includes thecontrol logic to control the mobile telecommunications device to use itsexisting components to examine, record, transmit and/or analyze aseismocardiogram. Thus, the cardiac performance monitoring system mayinclude executable logic that controls the mobile telecommunicationsdevice to detect vibration and/or position, and to guide the user intaking readings of cardiac performance.

In some variations, the cardiac performance monitoring system mayinclude an ECG monitoring component (e.g., electrodes, includingelectrodes on a case configured to hold the mobile telecommunicationsdevice as described in U.S. patent application Ser. No. 13/420,520).Thus the cardiac performance monitoring system may comprise a housing orcase for a mobile telecommunications device having one or moreelectrodes. The cardiac performance monitoring system may also be usedwithout the additional ECG monitoring electrodes.

For example, when placed on the chest of a user, the cardiac performancemonitoring systems disclosed herein can cause the mobiletelecommunications device to measure vibrations caused by the heartbeatto get a seismocardiogram (SCG) of the user. The user can convenientlyand easily use the mobile telecommunications device to take their ownSCG at their convenience, including in a home setting. This data may bestored and/or analyzed by the mobile telecommunications device, and/ortransmitted to a remote location (e.g., website) for analysis, storage,or further processing, including being added to the patient's medicalrecords, or being analyzed by a physician.

The methods and systems (cardiac performance monitoring system)described herein may also provide one or more indices of cardiac healthbased on the patient's SCG. In particular, the SCG detected by themobile telecommunications device may be analyzed to determine an indexof left ventricular performance. In some variations the methods andsystems record both an SCG and an ECG over the same time period.

The cardiac performance monitoring system can control thetelecommunications device to communicate with an ECG component to takean ECG of the patient. The SCG and ECG can be analyzed to determine theleft ventricular performance of the user. The cardiac performancemonitoring system can analyze the cardiac performance data to establisha baseline for the cardiac performance of the patient and to alert thepatient of any statistically significant changes in the cardiacperformance.

In some variations the cardiac performance monitoring system guides thepatient through the procedure for measuring an indicator of cardiacperformance. The cardiac performance monitoring system may also confirmthe steps, including that the patient (or user) has properly positionedthe device to measure cardiac performance. For example, the executablecontrol logic may detect that the mobile telecommunications device hasbeen placed properly on the patient's chest by confirming that themobile telecommunications device is flat (e.g., horizontal) bycontrolling the accelerometer and/or gyroscope that may be built intothe mobile telecommunications device (e.g., iPhone, android, etc.).Instructions and/or patient feedback may be visual, audible, tactile, orsome combination of these.

Cardiac performance data can be monitored remotely by a physician orother medical professional. The physician can receive an automaticnotification for any changes in the cardiac performance of the patientto evaluate changes in the mediation or treatment of the patient or theneed for immediate medical treatment.

For example, described herein are apparatuses comprising non-transitorycomputer-readable storage medium storing a set of instructions capableof being executed by a smartphone having an accelerometer. The set ofinstructions, when executed by the smartphone, causes the smartphone torecord a seismocardiogram (SCG) from the smartphone's accelerometer bydetecting vibrations on a patient's chest corresponding to heart motionfor a first time period. Further, the set of instructions, when executedby the smartphone, cause the smartphone to do at least one of: analyzethe SCG to determine an index of cardiac function, display the SCG,transmit the SCG, or store the SCG.

In general, a set of instructions on a non-transitory computer-readablestorage medium may comprise a program (e.g., software, firmware, or thelike) that can be executed by a processor. In most of the examplesdescribed herein the processor is part of a mobile telecommunicationsdevice such as a smartphone, however, any appropriate processor may beused.

The set of instructions on the non-transitory computer-readable storagemedium of may also, when executed by the smartphone, cause thesmartphone to receive an electrocardiogram (ECG) from the patient,wherein the ECG is taken over the first time period. In some variationsthe set of instructions is configured so that it controls acquisition ofthe ECG as well as acquisition of the SCG. In general, the ECG and SCGmay be collected/recorded over the same time period (e.g., having thesame start time and/or stop time), so that the two can be time-locked orcorrelated. The SCG and ECG may be collected at the same time intervalswhen discrete sampling is performed, or at different time intervals. Insome variations the ECG is collected using a device that is coupled tothe smart phone. For example, an ECG electrode module may be used inconjunction with the smartphone. The ECG module may include two or moreelectrodes for collecting an ECG. The module may communicate with thephone either directly via a connection (e.g., into an input port such asan audio jack) or indirectly via a wireless connection (e.g., radio,ultrasound, audible, optical, induction, etc.). In some variations theset of instructions (which may be referred to herein as logic or controllogic) on the non-transitory computer-readable storage medium may beconfigured to synchronize with the ECG module, so that collection of theECG and SCG can also be synchronized as discussed above.

In some variations the set of instructions is configured to analyze theSCG data on the smart phone. The set of instructions, when executed bythe smartphone, may be configured to cause the smartphone to analyze theSCG to determine the index of cardiac function in any appropriatemanner. For example, the set of instructions may be configured to havethe smart phone (e.g., a processor of the smart phone) take a ratio ofthe sum of isovolumetric contraction time (ICT) and isovolumetricrelaxation time (IRT) divided by the left ventricle ejection time (ET).A set of instructions on a non-transitory computer-readable storagemedium may, when executed by the smartphone, cause the smartphone toidentify two or more characteristic regions of the SCG. As described inmore detail below, the regions that the set of instructions mayconfigure the device (e.g., smartphone) to recognize may include a timepoint or region corresponding to: mitral valve closure, isovolumetriccontraction, aortic valve opening, rapid ejection, aortic valve closure,mitral valve opening, and rapid filling. These time points may be usedto measure or otherwise derive additional information about the SCG andthus cardiac health of the subject from whom the reading was taken.Characteristic regions may generally be recognized based on the overallshape of the SCG curve(s) or average SCG cycle(s). In some variations,additional information may be used to help identify characteristicregions. For example, a synchronized ECG (or average ECG(s)) may be usedto help identify one or more characteristic regions of an SCG. Forexample, a set of instructions, when executed by a smartphone, may causethe smartphone to identify two or more characteristic regions of the SCGusing an electrocardiogram (ECG) that is taken over the first timeperiod. When the ECG and SCG are synchronized, the R-wave peak, which isoften readily recognized from an ECG signal, (including an ECG takenfrom a pair of electrodes on a patient's chest, as shown below) mayindicate the location of the characteristic mitral closure (MC) peak, asshown in FIG. 6. Thus, the R-wave may be used as a fiduciary marker forthe characteristic MC in an SCG.

In general, multiple SCG cycles may be taken during the first timeperiod of recording an SCG. Each “cycle” of an SCG cycle corresponds toa single, and complete, cardiac cycle for that patient. When the timeperiod during which the SCG is acquired by the device is sufficientlylong (e.g., extending over more than one cardiac cycle), multiple cyclesmay be analyzed. As mentioned above, multiple cycles may be averaged toremove spurious noise or irregularities. For example, the apparatusincluding the set of instructions on the non-transitorycomputer-readable storage medium may be configured by the set ofinstructions to identify multiple SCG cycles taken during first timeperiod and to average the multiple SCG cycles. In some variations theSCG signal may be filtered, smoothed, and/or otherwise processed toenhance the signal received. High frequency filtering may be applied toremove noise. Similarly, smoothing may be performed to better identifycharacteristic regions of the SCG, which may be determined based onpeaks in the SCG. In some variations, rather than averaging thewaveforms of each (or a subset) of the SCG cycles recorded, theapparatus may be configured to average measurements taken from each (ora subset) of the SCGs. “Bad” or outlining SCG cycles may be rejected ornot included in the analysis. A rolling average (or updating average)may be performed as new SCG cycles are measured. For example, theapparatus may determine for each SCG cycle the time of mitral valveclosure (MC), aortic valve opening (AO), Aoritc valve closure (AC) andmitral valve opening (MO), and use these estimated times to derivevalues such as isolvolumetric contraction time (ICT or IVCT, equal tothe time from MC to AO), ejection time (ET, equal to the time from AO toAC)), and isovolumetric relaxation time (IRT or IVRT, equal to the timefrom AC to MO). The derived values (ICT, ET, IRT, etc.) may be averagedby SCG cycles. These values may also be used to derive one or moreindexes, and the index value may be based on the average values, or araw index value for each SCG cycle may be averaged (or both).

In general, the non-transitory computer-readable storage medium having aset of instructions may be configured so that the set of instructions,when executed by the smartphone, causes the smartphone to instruct thepatient how to record the SCG for determining an indicator of cardiacfitness/health. For example the set of instructions may instruct thesubject to position the smartphone against the patient's chest prior torecording the SCG. Instructing the subject may be done by presentingvisual (e.g., images, text, or both on the smartphone screen) and/oraudible (using the speaker of the smartphone) instructions to thesubject. The apparatus may instruct the subject/patient to place thesmartphone against the chest while lying down so that the smartphonerests against the chest, substantially flat. The smartphone may also beconfigured by the set of instructions to monitor the position of theapparatus while recording the SCG and/or ECG and stop the recording ifthe patient moves too much (which may lead to erroneous readings). Thus,for example, the non-transitory computer-readable storage mediumconfigured by the set of instructions, when executed by the smartphone,may cause the smartphone to verify the orientation of the smartphone andnotify the user if the orientation of the smartphone during the firsttime period was incorrect.

The smartphone may also be configured to indicate when the recording isongoing and/or when it has completed. The smartphone may also begenerally configured by the instructions to indicate the outcome of theSCG (e.g., good reading, bad reading, repeat reading, etc.) includingproviding an output of the SCG on the smartphone.

Another example, of an apparatus is a non-transitory computer-readablestorage medium in a smartphone having an accelerometer storing a set ofinstructions capable of being executed by the smartphone, that, whenexecuted by the smartphone, causes the smartphone to: record aseismocardiogram (SCG) from the smartphone's accelerometer by detectingvibrations on a patient's chest corresponding to heart motion for afirst time period; and receive an electrocardiogram (ECG) from thepatient over the first time period; analyze the SCG to determine anindex of cardiac function for the patient; and do at least one of:display, transmit and store the index of cardiac function. Any of thefeatures discussed above may also be included in this variation. Forexample, the set of instructions, when executed by the smartphone, maycause the smartphone to analyze the SCG to determine an index of cardiacfunction for the patient by identifying characteristic regions of theSCG using the ECG, such as by identifying two or more of: mitral valveclosure, isovolumetric contraction, aortic valve opening, rapidejection, aortic valve closure, mitral valve opening, and rapid filling.The set of instructions, when executed by the smartphone, may cause thesmartphone to analyze the SCG to determine an index of cardiac functionfor the patient by taking a ratio of the sum of isovolumetriccontraction time (ICT) and isovolumetric relaxation time (IRT) dividedby the left ventricle ejection time (ET).

Methods of estimating cardiac fitness/health are also described,including methods of using the apparatuses described above. For example,a method of determining an index of cardiac function for a patient usinga smartphone having an accelerometer may include: placing the smartphoneon the patient's chest; recording a seismocardiogram (SCG) for a firsttime period using the smartphone's accelerometer; and analyzing the SCGto determine an index of cardiac function.

In any of these variations, the method may also include the step ofreceiving an electrocardiogram (ECG) in the smartphone, wherein the ECGis recorded from the patient over the first time period. The receivedECG may be synchronized with the SCG. The synchronization may becontrolled by the logic running on the smartphone, which may triggerboth the recordings of the ECG and SCG, or the logic may be configuredto passively wait for the ECG recording to begin and thereafter triggerreading of SCG, although the time basis may be the same (e.g., the SCGand ECG may be time locked, sharing the same time axis).

In general, the apparatuses described herein may be used by a patient tohelp determine his or her own cardiac health. Thus, these devices may beused in a home or other non-clinical setting. The results may betransmitted to a clinician (physician, nurse, technician, etc.)immediately or after a delay, and/or placed in the patients file (e.g.,electrical medical record). Thus, any of these methods and devices maybe used by the patient/subject himself or herself, and may includeinstructions guiding the user (the patient/subject or a family member)in how to use the apparatus. For example, the step of placing thesmartphone on the patient's chest may comprise the patient placing thesmartphone on the patient's own chest; the apparatus may tell and/orshow the patient how to correctly place the apparatus.

In any of these variations the method may also include using thesmartphone to verify the orientation of the smartphone on the patient'schest before or during the first time period. For example, an internalgyroscope, level, or the like, may be used to determine and/or verifythe orientation of the smartphone before and/or during recording of theSCG.

Analyzing the SCG to determine an index of cardiac function may includeanalyzing the SCG using the smartphone to determine the index of cardiacfunction, for example, by taking a ratio of the sum of isovolumetriccontraction time (ICT) and isovolumetric relaxation time (IRT) dividedby the left ventricle ejection time (ET). The method may be used todetermine any index of cardiac function, including (but not limited to)the modified Tei index. In some variations, analyzing the SCG todetermine an index of cardiac function comprises identifying multipleSCG cycles taken during first time period and averaging the multiple SCGcycles. Averaging may be performed at the level of the waveform (e.g.,averaging each SCG cycle waveform after aligning them, e.g., by MC), orat the level of the characteristics extracted from each SCG cycle (suchas the ICT, ET, IRT, etc.). In some variations, analyzing the SCG todetermine an index of cardiac function comprises identifying multipleSCG cycles taken during the first time period using an electrocardiogram(ECG) that was recorded from the patient over the first time period

Analyzing the SCG to determine an index of cardiac function may compriseidentifying two or more characteristic regions of the SCG from theregions consisting of: mitral valve closure, isovolumetric contraction,aortic valve opening, rapid ejection, aortic valve closure, mitral valveopening, and rapid filling.

In any of the methods described herein, the SCG, including the SCGwaveform and/or an indicator of the quality of the SCG waveform, or aproxy for an SCG waveform (indicating that an SCG waveform was taken)may be displayed by the smartphone. The smartphone may also oralternatively display an ECG and/or the index for cardiac health, or asimplified indicator of the index (red light/danger, green light/good,yellow light/caution, etc.).

In any of these variations the method may also include transmitting theSCG and/or extracted information from the SCG and/or ECG. For examplethe SCG waveform(s) and/or the ECG waveforms may be transmitted toanother processor for analysis, rather than performing the analysis onthe smartphone, or in addition to performing the analysis on thesmartphone. For example, the method may include the step of transferringthe SCG and ECG data (and/or waveforms) to a remote server over theinternet for storage and/or analysis.

Another example of a method of determining an index of cardiac functionfor a patient using a smartphone having an accelerometer includes thesteps of: placing the smartphone on the patient's chest; recording aseismocardiogram (SCG) for a first time period using the smartphone'saccelerometer; receiving an electrocardiogram (ECG) in the smartphone,wherein the ECG is recorded from the patient over the first time period;and analyzing the SCG to determine an index of cardiac function. Any ofthe steps described above may be applied in this exemplary method aswell. For example, the method may include using the smartphone to verifythe orientation of the smartphone on the patient's chest before orduring the first time period. As mentioned, analyzing the SCG todetermine an index of cardiac function may comprise analyzing the SCGusing the smartphone to determine the index of cardiac function bytaking a ratio of the sum of isovolumetric contraction time (ICT) andisovolumetric relaxation time (IRT) divided by the left ventricleejection time (ET).

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a picture of a prior art method for measuring aseismocardiogram (SCG) and electrocardiogram (ECG) for a patient. Theimage is adapted from FIG. 3 of “Mechanisms Underlying IsovolumicContraction and Ejection Peaks in Seismocardiogram Morphology” by Gurevet al. (Journal of Medical and Biological Engineering, 32(2): 103-110(2012)).

FIG. 2 illustrates a subject/patient using a method and apparatus asdescribed herein and controlling a mobile telecommunications device (inthis example, an iPhone™) to detect an SCG and ECG for determining ameasure or index of cardiac function.

FIG. 3A is a schematic representation of one variation of back of amobile telecommunications device (e.g., smartphone) including a modulehaving sensors for measuring ECG (e.g., electrodes).

FIGS. 3B, 3C, 3D, and 3E show front, right side, back and left side,views respectively, of another variation of an apparatus including amobile telecommunications device configured for detecting SCG and/orECG.

FIG. 4 graphically illustrates an exemplary ECG waveform.

FIG. 5 illustrates a pair of synchronized ECG and SCG waveforms (for asingle ECG and SCG cycle).

FIG. 6 is an example of an SCG taken using a smartphone.

FIG. 7 is an exemplary chart illustrating steps that may be performed asdescribed herein.

DETAILED DESCRIPTION

In general, described herein are apparatuses (e.g., systems and devices,including software) and methods for determining one or more indicatorsof a subject's cardiac health using a mobile telecommunications device(e.g., smartphone). In particular, described herein are cardiacperformance monitoring apparatuses controlling a mobiletelecommunications device (e.g., smartphone) to detect and/or analyze apatient's seismocardiogram (SCG). The mobile telecommunications devicetypically includes an integrated accelerometer and optionally agyroscope. The methods and apparatuses described herein controloperation of the mobile telecommunications device to use theaccelerometer to detect a seismocardiogram and/or ballistocardiogram.For example, the accelerometer can be used to detect heart vibrations ofthe subject. As used herein a “subject” may be referred to as a patientor user. Heart vibrations may be used to get a seismocardiogram (SCG).In some variations the apparatus may control operation of the mobiletelecommunications device to analyze the SCG on the mobiletelecommunications device and/or upload the SCG to a remote site whereit can be analyzed or further analyzed.

In some variations, the apparatus may be used with or may include asystems (e.g., subsystem) having one or more sensors (and particularlyintegral sensors) for measuring electrocardiograms with the mobiletelecommunications device. For example, the methods or systems mayinclude a case connectable to the mobile telecommunications device sothat it forms an integral device not much larger than the mobiletelecommunications device that can detect both SCG and ECG. The ECGsensor (electrodes) can be integral to the mobile telecommunicationsdevice or attached to a case for the mobile telecommunications device.Two or more electrodes may be used to measure the electricalcharacteristics of the user or patient to take an ECG. In somevariations the electrodes (e.g., on a case for the mobiletelecommunications device) communicate wirelessly with thetelecommunications device, including transmitting coded data using anultrasonic transmission. The SCG and ECG can be analyzed to determinethe left ventricular performance of the patient or user. The methods orsystems may simultaneously detect SCG and ECG data.

The apparatuses and methods disclosed herein are generally adapted foruse with mobile telecommunications devices. This mobiletelecommunications device may be placed on the patient's chest so thatthe accelerometer of the mobile telecommunications device can measurevibrations in the chest to take an SCG. In variations including ECGelectrodes (e.g., when the mobile telecommunications device is housed ina case having electrodes for measuring an ECG), the electrodes can beused to measure electrical impulses on the chest to take an ECG. Themobile telecommunications device and electrodes can be used to measurecardiac parameters previously measured using larger equipment, requiringa technician, and/or multiple accessories or attachments.

The apparatuses and methods disclosed herein can be used by the patientto monitor a number of physical parameters using a handheld device, suchas a mobile telecommunications device (e.g., smartphone). The patientcan use the device to measure the cardiac parameters in the comfort oftheir home. The parameters or trend in the measured parameters can beanalyzed to look for any possible indications of a problem with thepatient's cardiac health.

In some variations, described herein are systems including a case devicethat may be used with a mobile telecommunications device. The casedevice may hold the mobile telecommunications device so that it forms anintegrated (single piece) unit than can be placed on the patient's chestto measure SCG and/or ECG as well as other cardiac parameters. Many ofthe patients with decreased cardiac health are older in age, thereforeit is important for the device to be convenient and easy to use at home.Separate pieces and complicated designs can be overwhelming for someusers thereby discouraging the patients from using the device. Separatepieces can also be easy to lose and more difficult to use for olderpatients.

The convenience for the patient to quickly and easily measure thebiological parameters is important because it can increase patient use.The more often the patient can measure their biological parameters thegreater the benefits for the patient. Tracking the patient's cardiacfunction can provide more data on the cardiac health of the patient andimprove the overall medical treatment. Additional data on the cardiachealth trends of the patient can increase the likelihood of earlydiagnosis of potential cardiac problems allowing for earlier treatmentand increased chances for resolving the problems prior to a catastrophiccardiac event requiring hospitalization.

Prior art methods have been used to generate an ECG and SCG for thepatient at the hospital or in a doctor's office. For example, prior artmethods include using a 12 lead system for generating an ECG for thepatient. FIG. 1 shows a setup for using a 12 lead system for generatingan ECG and a large accelerometer system for generating a SCG (See“Mechanisms Underlying Isovolumic Contraction and Ejection Peaks inSeismocardiogram Morphology” by Gurev et al. (2011)). As can be seen,this equipment requires use of a medical facility and a skilled personto setup and operate.

The methods and systems described herein can utilize a mobiletelecommunications device to measure the SCG using an accelerometer thatis already part of the mobile telecommunications device. The mobiletelecommunications device or a remote server can be used to analyze theSCG curve to determine additional cardiac data as well as acquire andprocess simultaneous ECG data. The ability for the patient to use asmartphone to take an SCG is an advantage over the prior art methodsbecause it doesn't require a trip to the doctor's office, the use oflarger equipment, or a skilled person to setup and operate.

The mobile telecommunications device can have a plurality of electrodesformed integrally to the exterior of the device, or on a case orattachment to the mobile telecommunications device, as illustrated inFIGS. 3A and 3B-3E. A case for a mobile telecommunications device canalso include a plurality of electrodes. For example, U.S. patentapplication Ser. No. 12/796,188, filed Jun. 8, 2010 and titled “HEARTMONITORING SYSTEM USABLE WITH A SMART PHONE OR COMPUTER,” now U.S. Pat.No. 8,509,882 discloses a device that includes electrodes for generatingan ECG. The device attaches to a smartphone or smartphone case. Theelectrodes can measure the electrical impulses on the patient's chestand take an ECG.

The systems and methods disclosed herein allow for a smartphone orhandheld computing device with a small electrode attachment integral tothe phone or phone case to simultaneously measure both the ECG and SCGfor the patient. The simultaneously acquired and synchronized ECG andSCG data can be used to calculate and derive a number of cardiacparameters for the patient. For example, the methods and devices cancontrol the mobile telecommunications device to determine patient heartrate, average heart rate, heart rhythm, and cardiac event timing via theECG and SCG. In some variations one or more of these indicators ofcardiac function are determined.

Index values can also be useful in determining the overall cardiachealth of the patient. One known index for measuring the cardiac healthof a patient is known as the Myocardial Performance Index (MPI) or theTei index. The Tei index was disclosed in “New index of combinedsystolic and diastolic myocardial performance: as simple andreproducible measure of cardiac function—a study in normals and dilatedcardiomyopathy” by Tei et al. (Journal of Cardiology 1995 26(6):357-66). The systems and methods disclosed herein can be used todetermine a modified Tei index for the patient, using the SCG datareceived by the mobile telecommunications device using the apparatusesand methods described.

Typically, the Tei index is lower in healthy patients and higher inpatients with cardiac problems. An increase in the Tei index can beindicative of potential problems with cardiac functions. The methods,systems, software, and devices disclosed herein can provide an earlywarning for possible heart failure by tracking the modified Tei indexfor the patient. If the Tei index increases then it signals for the needfor medical treatment or a modification in the medication that thepatient takes to treat cardiac problems. The advanced notice forproblems can possibly prevent catastrophic complications of cardiacfailure. The Tei (or modified Tei) index is just one example of an indexof cardiac function (or index of cardiac fitness) that may be determinedfrom the SCG and/or ECG. The methods and apparatuses described hereinmay be used to determine other indices of cardiac health, including flowvelocities (e.g., pulmonary venus flow velocity), cardiac loading(ventricular loading), and the like.

The apparatuses (e.g., devices and systems), and methods disclosedherein are advantageous over prior art apparatuses and methods becausethe patient can easily measure the cardiac parameters at theirconvenience at home using a hand held telecommunication device that doesnot require the use of additional accessories that can be easily lost orrequire complicated assembly. Additionally, the patient can makesophisticated measurements of their cardiac health without a trip to thedoctor or using commercial equipment that costs many thousands ofdollars and is only practical at hospitals and doctor's offices. Theadditional convenience allows for the patient to take their ownmeasurements at home, instead of at the doctor's office. The additionalmeasurements can be used to track the cardiac health of the patient overtime. The systems and methods described herein allow the patient to actas their own control. The cardiac health can then be tracked over timeand changes in the cardiac health relative the patient's own baselinecan be determined and can identify problems at an early stage to allowfor earlier treatment, such as modification of the medication or a visitto the doctor's office for evaluation.

Further, the apparatus (e.g., systems and devices) described herein maycommunicate with the smartphone and allow measurements and trends to besecurely and/or automatically and/or wirelessly transmitted tocaregivers. As used herein, the apparatus may be configured towirelessly communicate with a mobile telecommunications device (e.g.,smart phone). Although ultrasonic transmission is of particularinterest, it should be understood that, as used herein, wirelesscommunication (e.g., transmission of a signal) includes any appropriatewireless modality, including, but not limited to transmission of radiosignals, microwave signals, visible light signals, infrared signals,sonic signals, ultrasonic signals, and electromagnetic inductionsignals. Thus, the apparatus may be configured to broadcast and/orreceive via or more of: radio signals, microwave signals, visible lightsignals, infrared signals, sonic signals, including but not limited toultrasonic signals, and electromagnetic induction signals.

It is to be understood that the invention is not limited in itsapplication to the details of construction, experiments, exemplary data,and/or the arrangement of the components set forth in the followingdescription. The invention is capable of other embodiments or of beingpracticed or carried out in various ways. Also, it is to be understoodthat the terminology employed herein is for purpose of description andshould not be regarded as limiting.

In the following detailed description of embodiments of the disclosure,numerous specific details are set forth in order to provide a morethorough understanding of the disclosure. However, it will be apparentto one of ordinary skill in the art that the concepts within thedisclosure can be practiced without these specific details. In otherinstances, well-known features have not been described in detail toavoid unnecessarily complicating the description.

Telecommunications Device

As used herein mobile telecommunications device (telecommunicationsdevices) includes smartphones (e.g., iPhone™, Droid™ or other personalcommunications devices). In some variations mobile telecommunicationsdevice may also include some tablet computers (e.g., iPad™, tablet PCs,or the like), and other handheld computing devices.

The mobile telecommunications devices typically include an integralaccelerometer or may be adapted to include an accelerometer. The systemsdescribed herein include executable control logic to control theaccelerometer to measure vibrations on the patient's chest, such asvibrations caused by the patient's heartbeat (e.g., as, for example,x,y,z axis motion). The sampling rate for the accelerometer readings canbe tied to the processor speed of the mobile telecommunications device.In some cases the accelerometer sampling rate may be on the order of 100measurements per second. In some variations the telecommunicationsdevice may be controlled to adjust the sampling rate for theaccelerometer.

The mobile telecommunications device can include a gyroscope or may beadapted to include a gyroscope. The gyroscope can be used to verify thepositioning of the telecommunications device when in use by the patient,for example to verify the positioning of the telecommunications devicewhen the device is taking the SCG.

The telecommunications devices can include a GPS sensor or may beadapted to include a GPS sensor. The GPS sensor can be used to verifythe location of the telecommunications device when in use by thepatient, for example to verify the location of the telecommunicationsdevice when the device is taking the SCG.

The telecommunications device can be adapted to communicate with an ECGcomponent. The telecommunications device can communicate wirelessly withthe ECG component. In some embodiments the telecommunications device canbe configured to receive ultrasonic signals from the ECG component withencoded data corresponding to the ECG. Examples of ECG components andwireless (via ultrasonic transmission) data transfer of codedinformation that are usable with telecommunications devices aredisclosed in U.S. patent application Ser. No. 12/796,188, filed Jun. 8,2010 and titled “HEART MONITORING SYSTEM USABLE WITH A SMART PHONE ORCOMPUTER,” now U.S. Pat. No. 8,509,882, and U.S. patent application Ser.No. 13/108,738, filed May 16, 2011 and titled “WIRELESS, ULTRASONICPERSONAL HEALTH MONITORING SYSTEM,” now Publication No.US-2011-0301439-A1. The telecommunications devices can include (or maybe adapted to include) a microphone capable of receiving ultrasonicsound. A telecommunications device may include logic for translating thedigital signal encoded by the ultrasonic sound into a digital signalthat can be displayed, uploaded/transmitted, stored, and/or analyzed.

In general, a mobile telecommunications device can include amicroprocessor and logic for running software programs, such assmartphone applications. The telecommunications device can analyze andprocess the ECG and SCG data using a microprocessor and logic configuredto control the microprocessor. The ECG and SCG data can also be uploadedto a remote server to perform the data analysis.

The cardiac performance monitoring system may control the smartphone sothat it combines data and signals from other sensors built into thesmartphone such as a GPS, gyroscope, and accelerometer. Furtherprocessing of this data provides additional information related to theuser, such as speed, location, distance, steps, ECG, SCG, cadence, bodyposition, fall detection and energy expenditure. The cardiac performancemonitoring system may control the smartphone to take the raw signalsfrom the sensors and so that derived information can be displayed andstored locally on the smartphone, as well as being transmitted to theweb server over an internet connection. The web server may provide a webbrowser interface for real-time or retrospective display of the signalsand information received from the smartphone, and also includes furtheranalysis and reporting.

ECG Component

An ECG component can be included as part of a cardiac performancemonitoring system, and may include an electrode assembly configured tosense heart-related signals upon contact with a user's skin, and toconvert the sensed heart-related signals to ECG electrical signals. Aconverter assembly, integrated with, and electrically connected to theelectrode assembly, may be configured to receive the ECG electricalsignals generated by the sensor and output ECG sound signals through anaudio transmitter to a microphone in a computing device within range ofthe audio transmitter. The converter assembly is further configured tooutput the ECG signals as an ultrasonic FM sound signal.

In one embodiment, a smartphone protective case, usable as an ECGelectrode module or component, is provided as part of the cardiacperformance monitoring system. An electrode assembly, configured tosense heart-related voltage signals upon contact with a user's skin, andto convert the sensed heart-related signals to an ECG differentialelectric signal, is provided. A converter assembly, integrated with, andelectrically connected to the electrode assembly, is configured toconvert the electric ECG signal generated by the electrode assembly toan ultrasonic frequency modulated ECG sound signal having a carrierfrequency in the range of from about 17 kHz to about 40 kHz (e.g., about17 kHz to about 24 kHz), and further configured to output the ultrasonicfrequency modulated sound signal through an audio transmitter at asignal strength capable of being received by a smartphone positionedwithin the smartphone protective case.

The sensor assembly can include any suitable sensor operative to detecta physiological signal that a user desires to monitor. Nonlimitingexamples of such physiological signals include, but are not limited to,respiration, heartbeat, heart rate, electrocardiogram, electromyogram(EMG), electrooculogram (BOG), pulse oximetry, photoplethysmogram (PPG)and electroencephalogram (EEG).

Such electrodes can also be used to detect the electrical activity ofthe heart over time for electrocardiography (ECG). An ECG is ameasurement of the small electrical changes on the skin generated whenthe heart muscle depolarizes during each heart beat. The output from apair of electrodes is known as a differential lead. Small rises andfalls in the voltage between two electrodes placed on either side of theheart can be processed to produce a graphical ECG representation 22 suchas the example ECG shown in FIG. 4. In a typical ECG waveform 22, theECG waveform includes characteristic regions including the P wave, theQRS complex, the R wave, and the T wave.

In any of the examples described herein, an apparatus may include or beused with an ECG module component 10 and with an electrode assemblyconfigured to sense heart-related signals upon contact with a user'sskin, and to convert the sensed heart-related signals to an ECG electricsignal. As shown in FIGS. 3A and 3B-3E, a smartphone may include or beused with a case or other apparatus having an ECG module 10 includingelectrodes 350, 360. As discussed in detail below, the ECG module 10 maytransmit (e.g., wirelessly, including by an ultrasonic means) an ECGsignal to a smartphone 301. Software on the smartphone 301 can receiveand processes the ECG (e.g., wireless signal) in real-time, in additionto SCG data, as described below. The ECG and/or SCG can be furtherprocessed to calculate heart rate and identify arrhythmias. The SCG,ECG, heart rate, and rhythm information can be displayed on thesmartphone 301, stored locally for later retrieval, and/or transmittedin real-time to a web server via a 2G/3G/4G, WiFi or other Internetconnection. In addition to the display and local processing of the SCGand ECG data, the smartphone 301 can transmit, in real-time, the SCG,ECG, heart rate and rhythm data via a secure web connection for viewing,storage and further analysis via a web browser interface (using the2G/3G/4G or WiFi connectivity of, for example, the smartphone 301).Server software provides for storage, further processing, real-time orretrospective display and formulation of a PDF ECG rhythm strip documentand/or other reports and formats for printing remotely or locally.

The ECG module 10 can be configured in any way consistent with itsfunction, i.e., it should include electrodes available to make contactwith a user's skin on the hands, chest or other parts of the body, forobtaining the user's ECG, and be configured for transmitting the ECG toa receiving device. For example, a hand-held ECG module 10 can be shapedlike a credit card with two electrodes on one surface.

In another configuration, the ECG component 300 is usable as asmartphone protective case 300 as shown in FIGS. 3B-3E. One exampleconfiguration utilizes a “slip-on” protective case 300 for an iPhone® orother smartphone 301, the protective case 300 including an integratedECG electrode assembly 311, 313 and acquisition electronics (notvisible). Two or more (e.g., 3 or 4) electrodes may be used togenerating leads for collecting ECG data. The ECG electrodes in thisexample are located on the back of the case 300 opposite of the displayscreen 309 of the smartphone 301. The smartphone 301, in its ECG-adaptedprotective case 300, can be placed on a person's chest to generate amodified chest lead. The ECG can be measured by the acquisitionelectronics and converted into a wireless transmission signal forcommunicating to the smartphone 301 from the case 300. For example, insome variations the ECG signal is transmitted wirelessly to thesmartphone by ultrasound. Thus, the wireless transmission signal may bea frequency modulated ultrasonic signal encoding the ECG signal.Nonlimiting example of suitable carrier or center frequencies includefrom about 17 kHz to about 40 kHz, or in some embodiments from about 17kHz to 24 kHz. The frequency modulated ultrasonic signal may be outputby a miniature speaker or a piezoelectric buzzer. In some variations thecommunication between the smartphone and the ECG electrode modulesensing the ECG may be two-way (duplex). Further, the methods andapparatuses described herein may synchronize detection of ECG signalswith SCG detection, e.g., by initiating detection of SCG upon detectionof ECG signals (or vice versa).

Thus, a telecommunications device, such as a smartphone 301, can utilizeits built-in components (e.g., microphone, audio codec, and CPU) toacquire, digitize, demodulate, and process SCG and ECG data inreal-time. Also, the telecommunications device or smartphone 301 cancalculate a real-time heart rate measurement and determine a cardiacrhythm diagnosis like atrial fibrillation, or determine other indicatorsof cardiac health/fitness (e.g., a modified Tei index). The smartphone301 can utilize its 2G, 3G, 4G, Bluetooth® and WiFi connectivity totransmit the SCG and/or ECG and other data to a secure web server forreal-time distant display, storage and analysis. Also, the SCG and/orECG data can be stored locally on the smartphone for later review ortransmission. SCG and/or ECG data may be processed further and/orstored, and/or displayed, and/or transmitted on using any of thecommunications capabilities of the telecommunications device. Forexample, the data may be displayed on the smartphone and/or uploadedinto a medical database for storage and/or later review.

In any of the apparatuses and methods described herein, the SCG and/orECG component may be encrypted for transmission. Any appropriateencryption method may be used, including encryption methods that usekeys, such as data encryption standard (DES), advanced encryptionstandard (AES), and the like. In general any of the systems describedherein may encode the data, and an encryption key may be provided sothat it can be read and understood by a receiving telecommunications(e.g., phone, tablet, pad, etc.).

Cardiac Functions Determined from the SCG and/or ECG

A number of cardiac events, indices, and data can be derived from theSCG and/or ECG, including systolic and diastolic parameters for leftventricle performance. FIG. 5 illustrates a side-by-side synchronizedECG and SCG waveform with annotations showing characteristicscorresponding to specific points on the SCG and ECG curves. Further,FIG. 6 illustrates an annotated SCG taken using a mobiletelecommunications device 201 (iPhone™) on a subject as shown in FIG. 2.

In some variations the apparatus for determining an indicator of cardiacperformance includes control logic to process SCG and/or ECG data. Theapparatus may also be configured to both record and to analyze the SCGand/or ECG. For example, the apparatus (including control logic/aninstruction set) may be configured to determine characteristicparameters from the SCG as described herein.

For example, the upper trace in FIG. 5 corresponds to an ECG trace; thelower trace is an SCG waveform (a single cycle) synchronized with theECG trace. In FIG. 5, characteristic regions of the SCG reflect the timeof mitral valve closure (MC), isovolumetric contraction (IVC), aorticvalve opening (AO), rapid ejection (RE), aortic valve closure (AC),mitral valve opening (MO), and rapid filling (RF). In this example, thepeaks and/or troughs of the waveforms are taken to represent theapproximate time of each event, as labeled. A pre-ejection period (PEP)and left ventricle ejection time (LVET or ET) can be determined frompoints on the ECG and the SCG curves.

An SCG such as the one shown in FIGS. 5 and 6 can be used to determineapproximate timing of cardiac events. For example, left ventricleejection time (ET or LVET) can be calculated by determining the timefrom the aortic valve opening (AO) and the aortic valve closure (AC).The isovolumetric contraction time (ICT) can be calculated bydetermining the time between the mitral valve closure (MC) and theaortic valve opening (AO). The isovolumetric relaxation time (IRT) canbe calculated by determining the time between the aortic valve closure(AC) and the mitral valve opening (MO). Similarly, a pre-ejection period(PEP) can be calculated by determining the time between the Q wave onthe ECG and aortic valve opening (AO) on the ECG. A contractilitycoefficient can be calculated as PEP/LVET. The left ventricular fillingtime can be calculated by determining the time between the mitral valveopening and the mitral valve closure (MO-MC). The rapid ventricularfilling time can be calculated by determining the time between themitral valve opening (MO) and the rapid filling (RF).

Thus, the SCG alone gives a large number of cardiac characteristics thatmay be used to estimate cardiac fitness; in combination with the ECG,additional characteristics may be determined. Further the ECG, whensynchronized with the SCG, may be used to help identify characteristicson the SCG, and may be used to help identify individual SCG cycles. Forexample, the R-wave of the ECG may correspond to the MC in the SCG.

Thus, a mobile telecommunications device having an accelerometer may beused to detect an SCG by placing the mobile device 201 on the subject'schest when the subject is lying supine, as shown in FIG. 2. The mobiletelecommunications device may confirm subject compliance (e.g., that thedevice is properly positioned) using the device's gyroscope and/oraccelerometer. In some variations the method may also includeconcurrently (or over the same time period) measuring ECG, for example,with electrodes in a case in which the mobile telecommunications deviceis residing. These methods may be performed by a cardiac performancemonitoring system.

When taking the SCG (and/or ECG) signals may be recorded for apredetermined (or variable/situation dependent) period of time, andsignals averaged over that time period. For example, acomposite/average/filtered SCG signal and/or ECG signal may bedetermined from a window of measurement time (e.g., 10 second, 20second, 30 seconds, 40 seconds, 50 second, 1 minute, 2 minutes, 3minutes, 4 minutes, 5 minutes, etc.). The resulting SCG signal may bereferred to as a processed SCG signal. The processed SCG (and in somevariations ECG signal) may then be used to determine other parameters,as mentioned above. As mentioned, the ECG R-wave peak may be used as afiduciary for alignment of the ECG and/or SCG complexes (cycles) forsignal averaging which retains repeatable feature but may reduce noise.

In some variations, the cardiac performance monitoring system may thenanalyze the SCG and/or ECG to determine one or more parameter of cardiacperformance. For example, the cardiac performance monitoring system maybe configured to determine one or more index of cardiac function (indexof cardiac fitness). The parameters, including the index, may bedisplayed, stored, and/or uploaded to a remote site for patientmonitoring by a physician.

For example, in some variations, the cardiac performance monitoringsystem is configured to calculate a modified Tei index from the SCG.

Calculation of Modified Tei Index

The Tei index is typically calculated using pulsed Doppler ultrasound toobtain the cardiac event timing, e.g., using averages over three or morecardiac cycles. More recently, ultrasonic tissue Doppler Imaging (TDI)has been used to measure a beat-by-beat “modified Tei Index.” Describedherein are methods to calculate a modified Tei index using an SCG.

FIGS. 5 and 6 illustrate the use of SCG (alone or in conjunction with anECG) to calculate a modified Tei index. The modified Tei index can becalculated based on the isovolumetric relaxation time (IVRT or IRT),isovolumetric contraction time (IVCT or ICT), and left ventricularejection time (LVET or ET). The IRT, ICT, and ET can be derived orcalculated based on the SCG alone or in combination with a synchronizedECG. For example, time corresponding to the peak of the R wave can beused with landmarks from the SCG to calculate the isovolumetricrelaxation time (IRT), isovolumetric contraction time (ICT), andejection time (ET).

Specifically, a formula for calculating the modified Tei index is equalto the sum of the isovolumetric contraction time (ICT) and theisovolumetric relaxation time (IRT) divided by the ejection time:(ICT+IRT)/ET.

Another way to represent the Tei index is by the formula (a-b)/b where ais the interval between cessation and onset of the mitral inflow and bis the ejection time (ET). The ejection time corresponds to the ejectiontime of the left ventricular outflow. The IRT can be measured bysubtracting the interval between the R wave and the cessation of theleft ventricle (LV) outflow from the interval between the R wave and theonset of mitral inflow.

In some embodiments the modified Tei index and other cardiac functionscan be derived or estimated from just the SCG. The cardiac performancemonitoring apparatus described herein may include logic for calculatingthis index (e.g., modified Tei index determination logic) that mayoperate on the processor of the mobile telecommunications device usingthe SCG and in some variations the synchronized ECG signals.

The systems and methods described herein can therefore allow measurementof the modified Tie-index (and/or other cardiac fitness measures) on abeat-to-beat basis or an averaged basis. The patient may perform thesemeasurements at home, and could track them daily, hourly, etc. (multipletimes per day), or over many days (days, weeks, months, years). The datamay be saved locally (e.g. on the smartphone) and/or uploaded to adatabase or transmitted to a medical provided or monitoring service.

FIG. 2 and FIG. 6 illustrate the use of an apparatus as described hereinto detect SCG and calculate an indicator of cardiac fitness. In thisexample, as shown in FIG. 2, the patient records SCG data from thesmartphone placed on the chest. FIG. 6 illustrates one variation of theresulting SCG raw trace. In FIG. 6, the trace, taken from theaccelerometer of the smartphone, has been marked to indicatecharacteristic waveforms. This trace has not been filtered or smoothed,which may result in a more regular an easily read SCG waveform. In FIG.6 the LVET, ICT and IRT have been marked, based on the determination ofwhich peaks correspond to MC, AO, AC and MO. Additional characteristicshave also been marked. In FIG. 6, the modified Tei index may becalculated based on the values of ICT, IRT and LVET (e.g.,(ICT+IRT)/LVET). FIG. 6 is a single cycle of an SCG; additional SCGcycles may be analyzed and averaged.

Methods for Using the Mobile Telecommunication Devices

Prior art methods use large accelerometer to take the SCG. These devicesare only practical in the context of commercial medical facilities, forexample see the testing setup shown in FIG. 1. The devices and methodsdisclosed herein allow for the use of a handheld device, such as amobile telecommunications device to take the SCG as illustrated in FIG.2. The use of a compact and commonly available mobile telecommunicationdevice allows for the user to take the SCG at home instead of at acommercial medical facility.

The cardiac performance monitoring system described herein can use atelecommunications device at home by the user to measure the SCG and/orECG. The user can place the telecommunications device on their chest.The device is preferably in contact with the skin of the user's chest.The device can be placed near the bottom of the sternum of the user.This positioning works with the male and female anatomy.

FIG. 7 illustrates one method (and some of the control logic) for theoperation of the apparatus as described herein, in one variation. InFIG. 7, the user can place the device on their chest 701 while lyingdown in a supine position. The user is preferably resting during thetesting. Typically 30 seconds of data is sufficient. In some cases thedata can be collected for about 10 seconds or less, about 20 seconds orless, about 30 seconds or less, or about 60 seconds or less. In somecases a single heartbeat can be sufficient for taking the SCG and ECG.The apparatus records a seismocardiogram during the time period 703; insome variations an ECG may also be recorded during this same period oftime, and the synchronized ECG received by the apparatus 705. The SCG(and in some variations ECG data) may then be analyzed either on thesmartphone apparatus or (optionally) after transfer to another processor707. The SCG (and in some cases the ECG) may then be analyzed todetermine the location (e.g., the times during the SCG cycle) on SCGwaveform of characteristic regions (e.g., MC, ICT, AO, RE, AC, MO, etc.)709. These characteristic times can then be used to determine one ormore indicator or index of cardiac fitness (e.g., ventricularperformance and filling, Tei index, etc.) 711. Additional andalternative steps are also described herein, including displaying,storing and transmitting the SCG and/or ECG and data extracted from theSCG and/or ECG.

The telecommunications device can include a gyroscope that can be usedto verify the orientation of the device during testing to verify thatthe patient is in a supine position.

Previously it was only practical to measure the cardiac functions whenthe patient was at the hospital or doctor's office. The convenience ofat home measurement allows for more frequent measurements and trackingof the cardiac functions. More frequent measurements allows for trackingthe changes and trends of the user's cardiac functions. Tracking theuser's cardiac function over time allows for the determination of abaseline for the user's cardiac function. The user's own baseline can beused as a control value. The cardiac function data that is subsequentlymeasured can be compared to the user's baseline or control value.

Variations in cardiac function can be tracked over time. If thevariation from the baseline or control value exceeds a certain amount orthreshold then the user can be given a warning. The warning and data canbe sent to the user's doctor or nurse as well. The warning notificationcan be sent out for variations of about 10%, 20%, 30%, 40%, 50%, 60%,70%, 80%, 90%, or 100% from the baseline. For example, sudden increasesin the Tei index can be indicative of heart failure or imminent heartproblems.

The measure of the user's cardiac function can vary throughout the day,for example between morning, afternoon, and evening measurements. Theuser can be instructed to take the measurements at a certain time of theday or the data can be adjusted based on the typical variability betweenmeasurements taken during the morning, afternoon, and evening.

The user can be instructed to take measurements multiple times a day,once a day, once a week, or at other time intervals, and can be notifiedby phone call, email, SMS message, etc.

In some embodiments the data taken by the telecommunications device canbe presented to the user in numerical or graphical form. In someembodiments the data taken by the telecommunications device can beuploaded to a remote server. The data can later be accessed or presentedto a medical professional in numerical or graphical form.

In some embodiments the SCG can be taken by itself without taking aconcurrent ECG. The SCG by itself can be used to estimate the cardiacfunctions. In some embodiments, the SCG data can be analyzed with theassumption of a typical ECG response for the patient. In one example theECG and SCG could be taken at a medical facility and calibrated usingthe Doppler ultrasound or TDI measurements. The patient could then usethe mobile telecommunications device to measure the SCG and the softwarecould correlate the SCG data with the ultrasonically-derived SCG resultsto arrive at a representation of the cardiac function of the user.

In some embodiments the methods disclosed herein can be used to take anSCG and/or ECG of the patient by a doctor, nurse, or other medicalprofessional.

Smartphone Application and Software

The present application discloses a smartphone application that can beused to perform any of the methods, logic, calculations, and analysisdisclosed herein. Thus, the cardiac performance monitoring system mayinclude this application. This application (program, executable code,logic, etc.) is typically stored in a non-transient medium; thus mayinclude any non-transitory computer-readable storage medium storing aset of such instructions capable of being executed, e.g., by asmartphone.

The smartphone application includes instructions for thetelecommunications device to use an accelerometer to measure vibrations.

The smartphone application can include instructions for thetelecommunications device to communicate wirelessly with the ECGcomponent. The wireless communication can include communication byultrasonic signals. The ultrasonic signals can be encoded with digitalor analog data corresponding to the ECG reading.

The smartphone application includes instructions for thetelecommunications device to simultaneously collect ECG and SCG data.The ECG and SCG data can be time-synced based on the time clock of thetelecommunications device.

The smartphone application can include instructions to average the ECGand SCG data collected during the analyzed time interval.

Any of the data analysis disclosed herein can be performed by the logicor microprocessor contained on the telecommunications device. Any of thedata analysis disclosed herein can also be performed by a remote server.Any of the data analysis can be performed by a combination of both thetelecommunications device and the remote server.

The smartphone application can include instructions for analyzing theECG and SCG data to determine any of the peaks, points, or times ofinterest described herein.

The smartphone application can include instructions for thetelecommunications device to transmit data collected to a remote server.Any data collected by the telecommunications device can be uploaded andanalyzed by a remote server.

The smartphone application can include instructions to analyze thecollected data to establish a baseline or control or the patient. Theapplication can include trend monitoring to track changes in the cardiacfunction.

The smartphone application can send reminders to the patient to conducttests. The reminder can be sent via text message, e-mail, calendarreminders, phone notifications, or other methods. The reminder can besent based on the desired frequency of testing, for example, daily,weekly, or multiples times per day.

The smartphone application can analyze GPS and gyroscope data collectedby the telecommunications device while measuring the SCG to determinethe location and orientation of the device during measuring. Theapplication can provide a notification or error message if the gyroscopeindicates that the phone is incorrectly placed or if the patient is notin a supine or reclined position.

The smartphone application can include instructions to communicateremotely with a remote server or the internet. The application can alsoallow for remote monitoring by a medical professional.

The smartphone application can include instructions to notify the useror a medical professional if the variations from the baseline or controlvalue exceed a certain amount or threshold. The warning and data can besent to the user's doctor or nurse. The warning notification can be sentout for variations of about 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%,or 100% from the baseline.

The cardiac performance monitoring systems described herein may also beconfigured to determine one or more of cardiac rhythm (includingdetection of NSR or AF), and/or heart rate, and/or heart ratevariability. For example, SCG may be used to determine heart rate (orheart rate variability). The SCG may also be used to detect respirationand the respiratory cycle components (e.g., by examining thelow-frequency components) and respiratory rate.

In some variations, the cardiac performance monitoring system may alsoinclude a “paced breathing” module to guide a patient through theappropriate paced breathing session while the smartphone is in contactand measuring SCG and/or ECG, from which heart rate variability (HRV)could be determined. This may allow monitoring of the status of theirheart failure by evaluating the sympathetic-parasympathetic balance oftheir autonomic nervous system. Decreased HRV is an early warning of CHFdecompensation.

Additional Applications

The concepts disclosed in the present application are applicable to anyapplication where monitoring cardiac health and function over time isdesirable. The convenience of using the testing methods disclosed hereinfor at-home testing allows for the patient to develop a baseline valueto represent their cardiac health. The cardiac health can be monitoredover time to look for any changes in the cardiac health of the patient.

The methods can be used by heart transplant patients to monitor theircardiac health after receiving a transplant. A significant change in thecardiac function can be indicative of the body rejecting thetransplanted organ. Early detection of potential problems with thetransplanted organ can signal the need for early treatment or diagnosisand possibly prevent a fatal event.

Some drug treatments can cause complications with the heart function ina patient. The ability to monitor the overall cardiac function andloading status can be useful to determine when and if the drug treatmentcauses any adverse effects on the cardiac function of the patient. Forexample, some chemotherapy medications can be toxic to the heart. Themethods disclosed herein can be used to watch for any decreases in thecardiac function of the patient. If a statistically significant decreasein the cardiac function is observed then the dosage of the medicationcan be decreased or another medication could be substituted.

The telecommunications devices with the accelerometer can be used tomeasure trembling or shaking in the patient. For example, the devicescan be used to measure shaking in patients having Parkinson's disease.

The respiratory rate of the user can be determined using thetelecommunications device and accelerometer. The vibrations on theuser's chest can indicate the breathing rate in addition to theheartbeat. The measured vibrations can be analyzed to detect the peaksin the signal and apply a low pass filter to remove some of the datacorresponding to the heartbeat. The data can then be analyzed to extractdata on the respiratory rate of the user.

When a feature or element is herein referred to as being “on” anotherfeature or element, it can be directly on the other feature or elementor intervening features and/or elements may also be present. Incontrast, when a feature or element is referred to as being “directlyon” another feature or element, there are no intervening features orelements present. It will also be understood that, when a feature orelement is referred to as being “connected”, “attached” or “coupled” toanother feature or element, it can be directly connected, attached orcoupled to the other feature or element or intervening features orelements may be present. In contrast, when a feature or element isreferred to as being “directly connected”, “directly attached” or“directly coupled” to another feature or element, there are nointervening features or elements present. Although described or shownwith respect to one embodiment, the features and elements so describedor shown can apply to other embodiments. It will also be appreciated bythose of skill in the art that references to a structure or feature thatis disposed “adjacent” another feature may have portions that overlap orunderlie the adjacent feature.

Terminology used herein is for the purpose of describing particularembodiments only and is not intended to be limiting of the invention.For example, as used herein, the singular forms “a”, “an” and “the” areintended to include the plural forms as well, unless the context clearlyindicates otherwise. It will be further understood that the terms“comprises” and/or “comprising,” when used in this specification,specify the presence of stated features, steps, operations, elements,and/or components, but do not preclude the presence or addition of oneor more other features, steps, operations, elements, components, and/orgroups thereof. As used herein, the term “and/or” includes any and allcombinations of one or more of the associated listed items and may beabbreviated as “/”.

Spatially relative terms, such as “under”, “below”, “lower”, “over”,“upper” and the like, may be used herein for ease of description todescribe one element or feature's relationship to another element(s) orfeature(s) as illustrated in the figures. It will be understood that thespatially relative terms are intended to encompass differentorientations of the device in use or operation in addition to theorientation depicted in the figures. For example, if a device in thefigures is inverted, elements described as “under” or “beneath” otherelements or features would then be oriented “over” the other elements orfeatures. Thus, the exemplary term “under” can encompass both anorientation of over and under. The device may be otherwise oriented(rotated 90 degrees or at other orientations) and the spatially relativedescriptors used herein interpreted accordingly. Similarly, the terms“upwardly”, “downwardly”, “vertical”, “horizontal” and the like are usedherein for the purpose of explanation only unless specifically indicatedotherwise.

Although the terms “first” and “second” may be used herein to describevarious features/elements, these features/elements should not be limitedby these terms, unless the context indicates otherwise. These terms maybe used to distinguish one feature/element from another feature/element.Thus, a first feature/element discussed below could be termed a secondfeature/element, and similarly, a second feature/element discussed belowcould be termed a first feature/element without departing from theteachings of the present invention.

As used herein in the specification and claims, including as used in theexamples and unless otherwise expressly specified, all numbers may beread as if prefaced by the word “about” or “approximately,” even if theterm does not expressly appear. The phrase “about” or “approximately”may be used when describing magnitude and/or position to indicate thatthe value and/or position described is within a reasonable expectedrange of values and/or positions. For example, a numeric value may havea value that is +/−0.1% of the stated value (or range of values), +/−1%of the stated value (or range of values), +/−2% of the stated value (orrange of values), +/−5% of the stated value (or range of values), +/−10%of the stated value (or range of values), etc. Any numerical rangerecited herein is intended to include all sub-ranges subsumed therein.

Although various illustrative embodiments are described above, any of anumber of changes may be made to various embodiments without departingfrom the scope of the invention as described by the claims. For example,the order in which various described method steps are performed mayoften be changed in alternative embodiments, and in other alternativeembodiments one or more method steps may be skipped altogether. Optionalfeatures of various device and system embodiments may be included insome embodiments and not in others. Therefore, the foregoing descriptionis provided primarily for exemplary purposes and should not beinterpreted to limit the scope of the invention as it is set forth inthe claims.

The examples and illustrations included herein show, by way ofillustration and not of limitation, specific embodiments in which thesubject matter may be practiced. As mentioned, other embodiments may beutilized and derived there from, such that structural and logicalsubstitutions and changes may be made without departing from the scopeof this disclosure. Such embodiments of the inventive subject matter maybe referred to herein individually or collectively by the term“invention” merely for convenience and without intending to voluntarilylimit the scope of this application to any single invention or inventiveconcept, if more than one is, in fact, disclosed. Thus, althoughspecific embodiments have been illustrated and described herein, anyarrangement calculated to achieve the same purpose may be substitutedfor the specific embodiments shown. This disclosure is intended to coverany and all adaptations or variations of various embodiments.Combinations of the above embodiments, and other embodiments notspecifically described herein, will be apparent to those of skill in theart upon reviewing the above description.

What is claimed is:
 1. A non-transitory computer-readable storage mediumstoring a set of instructions capable of being executed by a smartphonehaving an accelerometer, that, when executed by the smartphone, causesthe smartphone to record both a seismocardiogram (SCG) from thesmartphone's accelerometer by detecting vibrations on a patient's chestcorresponding to heart motion for a first time period and to detect anelectrocardiogram (ECG) from the patient's chest, further wherein theset of instructions, when executed by the smartphone, cause thesmartphone to do at least one of: analyze the SCG to determine an indexof cardiac function, display the SCG, transmit the SCG, store the SCG,display the ECG, transmit the ECG, or store the ECG.
 2. Thenon-transitory computer-readable storage medium of claim 1, furtherwherein the set of instructions, when executed by the smartphone, causesthe smartphone to concurrently record the SCG and detect the ECG fromthe patient over the first time period.
 3. The non-transitorycomputer-readable storage medium of claim 1, further wherein the set ofinstructions, when executed by the smartphone, causes the smartphone toanalyze the SCG to determine the index of cardiac function bydetermining a Tei index or a modified Tei index.
 4. The non-transitorycomputer-readable storage medium of claim 1, further wherein the set ofinstructions, when executed by the smartphone, causes the smartphone todetermine an index using an interval between cessation and onset of themitral inflow and an ejection time (ET) of the left ventricular outflow.5. The non-transitory computer-readable storage medium of claim 1,wherein the set of instructions, when executed by the smartphone, causesthe smartphone to identify two or more characteristic regions of the SCGfrom the regions consisting of: mitral valve closure, isovolumetriccontraction, aortic valve opening, rapid ejection, aortic valve closure,mitral valve opening, and rapid filling.
 6. The non-transitorycomputer-readable storage medium of claim 1, wherein the set ofinstructions, when executed by the smartphone, causes the smartphone toidentify two or more characteristic regions of the SCG using anelectrocardiogram (ECG) that is taken over the first time period.
 7. Thenon-transitory computer-readable storage medium of claim 1, wherein theset of instructions, when executed by the smartphone, causes thesmartphone to instruct the patient to position the smartphone againstthe patient's chest prior to recording the SCG.
 8. The non-transitorycomputer-readable storage medium of claim 1, wherein the set ofinstructions, when executed by the smartphone, causes the smartphone toverify the orientation of the smartphone and notify the user if theorientation of the smartphone during the first time period wasincorrect.
 9. The non-transitory computer-readable storage medium ofclaim 1, wherein the set of instructions, when executed by thesmartphone, causes the smartphone to identify multiple SCG cycles takenduring first time period and to average the multiple SCG cycles.
 10. Thenon-transitory computer-readable storage medium of claim 1, wherein theset of instructions, when executed by the smartphone, causes thesmartphone to identify multiple SCG cycles using an electrocardiogram(ECG) that was taken over the first time period.
 11. A method ofdetermining an index of cardiac function for a patient using asmartphone having an accelerometer, the method comprising: placing thesmartphone on the patient's chest; recording a seismocardiogram (SCG)for a first time period using the smartphone's accelerometer; detectingan ECG using the smartphone; analyzing the SCG and to determine an indexof cardiac function; and performing one or more of: displaying the SCG,transmitting the SCG, storing the SCG, displaying the ECG, transmittingthe ECG, or storing the ECG.
 12. The method of claim 11, further whereinrecoding the SCG and detecting the ECG are both performed over the firsttime period.
 13. The method of claim 11, wherein placing the smartphoneon the patient's chest comprises the patient placing the smartphone onthe patient's own chest.
 14. The method of claim 11, further comprisingusing the smartphone to verify the orientation of the smartphone on thepatient's chest before or during the first time period.
 15. The methodof claim 11, further comprising transmitting the SCG and ECG to aprocessor remote to the smartphone for analysis.
 16. The method of claim11, wherein analyzing the SCG to determine an index of cardiac functioncomprises analyzing the SCG using the smartphone to determine one ormore characteristic times including one or more of: mitral valve closure(MC), aortic valve opening (AO), Aoritc valve closure (AC) and mitralvalve opening (MO), isolvolumetric contraction time (ICT) rapid ejection(RE), rapid filling (RF).
 17. The method of claim 11, wherein analyzingthe SCG to determine an index of cardiac function comprises identifyingmultiple SCG cycles taken during first time period and averaging themultiple SCG cycles.
 18. The method of claim 11, wherein analyzing theSCG to determine an index of cardiac function comprises identifyingmultiple SCG cycles taken during the first time period using the ECG.19. The method of claim 11, wherein analyzing the SCG to determine anindex of cardiac function comprises using an interval between cessationand onset of the mitral inflow and an ejection time (ET) of the leftventricular outflow to determine an index.
 20. The method of claim 11,wherein analyzing the SCG to determine an index of cardiac functioncomprises determining a Tei index or a modified Tei index.